Deep Brain Stimulation for Movement Disorders

Deep Brain Stimulation for Movement Disorders
October 13-14, 2016 - Würzburg, Germany

 
Deep Brain Stimulation for Movement Disorders takes place October 13-14, 2016, in Würzburg, Germany.Course Description

More than 100,000 patients worldwide have been treated by deep brain stimulation (DBS) for a drug refractory movement disorder.  General neurologists will be increasingly confronted with the management of these patients, who suffer from chronic neurological conditions, such as Parkinson's disease, and require lifelong care. 

This advanced course is intended for neurologists, neurosurgeons or nurse practitioners already involved in the care of patients with deep brain stimulation. The course will focus on standards of care in the preoperative, intraoperative and postoperative patient management, optimal definition of the implant target, a comparison of programming options in different DBS devices, advanced programming options including visualized programming tools and troubleshooting for failed DBS surgery and various therapy related adverse effects.

Learning Objectives  

At the conclusion of this activity, you should be able to accomplish the following:

  • Provide an in-depth overview of the selection process of candidates for deep brain stimulation in various subtypes of Parkinson’s disease, dystonia and tremor
  • Outline the efficacy and associated risks for DBS in various subtypes of Parkinson’s disease, dystonia and tremor
  • List the different electrical parameters that can be adjusted for DBS and outline their biological effect including advanced programming options such as interleaving, multiple independent current control, current steering, etc.
  • Describe the strategies for adjustment of medication and DBS settings, especially for Parkinson’s disease, and discuss troubleshooting strategies for dysarthria, balance problems, gait problems, and neuropsychiatric problems
  • Describe the strategies for analyzing the causes of “failed DBS surgery” and solutions
  • Describe the indirect and direct stereotactic definition of all implant targets (STN, GPi, VIM, VOA, subthalamic area)
  • List key points that describe the long-term management of DBS patients
     
Recommended Audience

This course is intended for movement disorder specialists, functional neurosurgeons, nurse practitioners and trainees who are already involved in the selection, intra- or postoperative management of patients with movement disorders (tremor, dystonia, Parkinson’s disease, etc.) treated by deep brain stimulation surgery and want to strengthen their knowledge in this field.

Venue  

NOVUM Conference Center
Schweinfurter Str. 11
Würzburg

CME Accreditation

The International Parkinson and Movement Disorder Society is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS).

The Management of Advanced Parkinson’s disease with Infusion Therapies course is designated for a maximum of 9 hours of European external CME credits. Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found online.

Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.

Top